Innovation Grand Rounds with Zeynep Madak-Erdogan
- Event Type
- Seminar/Symposium
- Sponsor
- Carle Illinois College of Medicine
- Location
- Medical Sciences Building Lecture Hall, Room 274
- Virtual
- Join online
- Date
- Oct 31, 2022 8:30 am
- Speaker
- Professor Zeynep Madak-Erdogan
- Registration
- Registration
- Contact
- Taylor Young
- taylory@illinois.edu
- Views
- 2
Friday, November 11
12–1 p.m. Presentation by Zeynep Madak-Erdogan, Ph.D.
1–1:30 p.m. Questions & DialogueRegister here to join colleagues in person at MSB Lecture Hall (Room 274) *
(Registration closes at 4:30 pm on Monday, November 7)
Or Attend Virtually via Zoom call-inZip code is the best predictor of health outcomes. Where people live affects their exposure to health risks and access to care. Cancer health disparities are differences in incidence, disease outcomes, survivorship, quality of life after cancer treatment, and burden of cancer. Zeynep Madak-Erdogan will present epidemiological and molecular data supporting a utility for spatial information predicting cancer risk and identifying molecular differences and vulnerabilities to understand breast and lung cancer disparities. She will include examples of how these novel findings can be used to mitigate cancer disparities.
Professor Zeynep Madak-Erdogan is the Sylvia D. Stroup Scholar of Nutrition and Cancer, a Health Innovation Professor at Carle Illinois College of Medicine, Graduate College Faculty Fellow, and the Director of Women’s Health, Hormones and Metabolism lab at the University of Illinois Urbana-Champaign. She is also the education program leader at the Cancer Center at Illinois. She received her Ph.D. and undertook postdoctoral studies on mechanisms of estrogen receptor action at UIUC, then joined the Department of Food Science and Human Nutrition at UIUC in 2014. Her lab uses various animal and 3D-reengineered models, as well as advanced statistical and computational analysis, to understand how nutrients, environmental toxicant exposures, and hormones impact metabolic health and hormone-dependent cancer outcomes.